SEPTOCAINE
LOE Approachingarticaine hydrochloride and epinephrine
NDAINJECTIONINJECTABLE
Approved
Apr 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Septocaine is an injectable local anesthetic combining articaine hydrochloride with epinephrine for infiltration and nerve block anesthesia. It is used primarily in dental procedures to provide local anesthesia with hemostasis. Articaine is an amide-type local anesthetic that rapidly penetrates tissue, with epinephrine prolonging duration and reducing systemic absorption.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100); team size and investment likely stabilizing or declining as patent protection weakens.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Septocaine offers limited career growth potential given the approaching LOE and zero linked job openings. This role is best suited for professionals seeking stable, maintenance-focused commercial experience in a mature dental anesthetic market rather than high-growth opportunity.
Brand ManagerField Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.